Eterna Therapeutics
ERNA
$1.78
Share price
-2.20%
Change (1 day)
-41.64%
Change (1 year)
Categories
Earnings for Eterna Therapeutics (ERNA)
Earnings in 2023 (TTM): -$20.53 M
According to Eterna Therapeutics's latest financial reports the company's current earnings (TTM) are -$20.53 M. In 2022 the company made an earning of -$24.51 M an increase over its 2021 earnings that were of -$0.13 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Eterna Therapeutics from 2020 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$20.53 M | -16.24% |
| 2022 | -$24.51 M | -80.08% |
| 2021 | -$0.13 B | 1596.7% |
| 2020 | -$7.25 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $8.39 B | -41,010.97% | 🇫🇷 France |
 Baxter BAX | -$47 M | 129.03% | 🇺🇸 USA |
 Omeros Corporation OMER | -$0.15 B | 630.94% | 🇺🇸 USA |
 Geron GERN | -$0.18 B | 756.76% | 🇺🇸 USA |
 Genetic Technologies GENE | -$3.8 M | -81.51% | 🇦🇺 Australia |
 Teva Pharmaceutical Industries TEVA | $0.40 B | -2,073.59% | 🇮🇱 Israel |
 Bio-Techne TECH | $0.26 B | -1,395.01% | 🇺🇸 USA |